Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
J0fdEkSt9n9DDtWG
Listen
Français